Plowman, R, et al.
The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. Journal of Hospital Infection
2001; 47: 198–209.
Coello, R, et al.
Adverse impact of surgical site infections in English hospitals. Journal of Hospital Infection
2005; 60: 93–103.
Johnson, AP, et al.
Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. Journal of Antimicrobial Chemotherapy
2012; 67: 802–809.
Wilson, J, et al.
Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clinical Microbiology and Infection
2011; 17: 451–458.
Duerden, B, et al.
The Control of methicillin-resistant Staphylococcus aureus blood stream infections in England. Open Forum Infectious Diseases
2015; 2: ofv035.
Coia, JE, et al.
Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection
2006; 63 (Suppl. 1): S1–44.
Stone, SP, et al.
Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. British Medical Journal
2012; 344: e3005.
HM Treasury. PSA Delivery agreement 19: ensure better care for all. October 2007.
Wilcox, MH, et al.
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clinical Infectious Diseases
2012; 55: 1056–1063.
Fuller, C, et al.
The national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012. PLoS ONE
2013; 8: e74219.
Monnet, DL, Frimodt-Moller, N. Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus
. Emerging Infectious Diseases
2001; 7: 161–163.
Monnet, DL, et al.
Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000. Emerging Infectious Diseases
2004; 10: 1432–1441.
MacKenzie, FM, et al.
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clinical Microbiology and Infection
2007; 13: 269–269.
Tacconelli, E, et al.
Does antibiotic exposure increase the risk methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy
2008; 61: 26–26.
Stone, SP, et al.
The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients. Age and Ageing
1998; 27: 561–568.
Nicastri, E, et al.
Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital. New Microbiologica
2008; 31: 519–525.
Ellington, MJ, et al.
Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. Journal of Antimicrobial Chemotherapy
2010; 65: 446–448.
Cremniter, J, et al.
Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections. Journal of Clinical Microbiology
2010; 48: 1428–1431.
Hope, R, et al.
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001–06. Journal of Antimicrobial Chemotherapy
2008; 62 (Suppl. 2): ii65–ii74.
Hickson, CJ, et al.
Prophylactic antibiotics in elective hip and knee arthroplasty: an analysis of organisms reported to cause infections and National survey of clinical practice. Bone and Joint Research
2015; 4: 181–189.
Horner, C, Mawer, D, Wilcox, M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
Journal of Antimicrobial Chemotherapy
2012; 67: 2547–2559.
Ashiru-Oredope, D, et al.
Improving the quality of antibiotic prescribing in the NHS by developing a new antimicrobial stewardship programme: Start Smart – Then Focus. Journal of Antimicrobial Chemotherapy
2012; 67 (Suppl. 1): i51–i63.
Brunner, M, et al.
Surgery and intensive care procedures affect the target site distribution of piperacillin. Critical Care Medicine
2000; 28: 1754–1759.
Markantonis, SL, et al.
Effects of blood loss and fluid volume replacement on serum and tissue gentamicin concentrations during colorectal surgery. Clinical Therapeutics
2004; 26: 271–281.
Velissaris, D, et al.
Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review. Journal of Clinical Medicine Research
2014; 6: 227–233.
Livermore, DM, et al.
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001–06. Journal of Antimicrobial Chemotherapy
2008; 62 (Suppl. 2): ii41–ii54.
Pitout, JD, Laupland, KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infectious Diseases
2008; 8: 159–166.
Nordmann, P, Naas, T, Poirel, L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases
2011; 17: 1791–1798.
Worth, LJ, et al.
Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive Victorian surveillance program, 2002–2013. Infection Control & Hospital Epidemiology
2015; 36: 409–416.
Hidron, AI, et al.
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control & Hospital Epidemiology
2008; 29: 996–1011.
Sievert, DM, et al.
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection Control & Hospital Epidemiology
2013; 34: 1–14.
Kallen, AJ, et al.
Health care-associated invasive MRSA infections, 2005–2008. Journal of the American Medical Association
2010; 304: 641–648.
Lessa, FC, et al.
Burden of Clostridium difficile infection in the United States. New England Journal of Medicine
2015; 372: 825–834.
Magill, S, et al. Point prevalence survey of antimicrobial use in U.S. acute care hospitals. ID Week 2012, October 2012; San Diego, USA.
Evans, SR, et al.
Desirability of outcome ranking (DOOR) and response adjusted for days of antibiotic risk (RADAR). Clinical Infectious Diseases
2015; 61: 800–806.